Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was mentioned in BioWorld, in “FDA Wins Kudos from Industry in Combo Product GMP Final,” by Mark McCarty.
Following is an excerpt:
The FDA's final guidance for combination product good manufacturing practices (GMPs) grew by 10 pages compared to the draft guidance, but the final product was hailed as "a good guidance document" by Bradley Merrill Thompson, of Epstein Becker & Green, the law firm that has represented the Combination Products Coalition on combo product regulatory matters before the FDA.
